These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 1104742)
1. Requirement for T cells in the production of migration inhibitory factor. Bloom BR; Shevach E J Exp Med; 1975 Nov; 142(5):1306-11. PubMed ID: 1104742 [TBL] [Abstract][Full Text] [Related]
2. The production of migration inhibition factor by B and T cells of the guinea pig. Yoshida T; Sonozaki H; Cohen S J Exp Med; 1973 Oct; 138(4):784-97. PubMed ID: 4582841 [TBL] [Abstract][Full Text] [Related]
3. Alloantiserum-induced inhibition of migration inhibition factor production in immune response gene-controlled immune systems. Ben-Sasson SZ; Shevach E; Green I; Paul WE J Exp Med; 1974 Aug; 140(2):383-95. PubMed ID: 4603011 [TBL] [Abstract][Full Text] [Related]
4. Antigen-nonspecific and specific suppression of lymphokine production in desensitized guinea pigs. Kobayashi K; Suko M; Yoshida T; Cohen S Cell Immunol; 1986 Feb; 97(2):325-34. PubMed ID: 2943427 [TBL] [Abstract][Full Text] [Related]
5. Detection of human contact sensitivity to dinitrochlorobenzene by the migration inhibiton test. Nishioka K J Invest Dermatol; 1976 Jun; 66(6):351-4. PubMed ID: 778281 [TBL] [Abstract][Full Text] [Related]
6. Cellular localization of anti-DNP-PLL and anticonveyor albumin antibodies in genetic nonresponder guinea pigs immunized with DNP-PLL albumin complexes. Green I; Vasalli P; Benacerraf B J Exp Med; 1967 Mar; 125(3):527-36. PubMed ID: 5334546 [TBL] [Abstract][Full Text] [Related]
7. Soluble factors in tolerance and contact sensitivity to 2,4-dinitrofluorobenzene in mice. IV. Characterization of migration inhibition factor-producing lymphocytes and genetic requirements for activation. Moorhead JW; Murphy JW; Harvey RP; Hayes RL; Fetterhoff TJ Eur J Immunol; 1982 May; 12(5):431-6. PubMed ID: 7047175 [TBL] [Abstract][Full Text] [Related]
8. Suppression of B cell MIF production by T cells and soluble T cell-derived factors. Cohen S; Yoshida T J Immunol; 1977 Aug; 119(2):719-21. PubMed ID: 328780 [TBL] [Abstract][Full Text] [Related]
9. Antigen and mitogen induced production of macrophage migration inhibitory factor in the mouse. Altboum I; Pick E Int Arch Allergy Appl Immunol; 1979; 60(1):29-43. PubMed ID: 378863 [TBL] [Abstract][Full Text] [Related]
10. Priming or tolerization of the B- and Th2-dependent immune response by the oral administration of OVA-DNP is determined by the antigen dosage. Franco L; Benedetti R; Ferek GA; Massouh E; Fló J Cell Immunol; 1998 Nov; 190(1):1-11. PubMed ID: 9826441 [TBL] [Abstract][Full Text] [Related]
11. Temporal dependence of the inhibition by cytochalasin B of antigen-initiated migration inhibition factor production. Sasson SZ; Rosenthal AS J Immunol; 1975 Oct; 115(4):1140-2. PubMed ID: 1100722 [TBL] [Abstract][Full Text] [Related]
12. The specificity of cellular immune responses in guinea pigs. I. T cells specific for 2,4-dinitrophenyl-o-tyrosyl residues. Janeway CA; Cohen BE; Ben-Sasson SZ; Paul WE J Exp Med; 1975 Jan; 141(1):42-55. PubMed ID: 46912 [TBL] [Abstract][Full Text] [Related]
13. Functional activation of immune lymphocytes by antigenic stimulation in cell-mediated immunity. IV. Role of macrophage and its soluble factor in antigen-induced MIF production of immune T lymphocytes. Yamamoto Y; Onoue K J Immunol; 1979 Mar; 122(3):942-8. PubMed ID: 376710 [TBL] [Abstract][Full Text] [Related]
14. Transfer of responsiveness to hapten conjugates of poly-L-lysine and of a copolymer of L-glutamic acid and L-lysine to lethally irradiated nonresponder guinea pigs by bone marrow or lymph node and spleen cells from responder guinea pigs. Foerster J; Green I; Lamelin JP; Benacerraf B J Exp Med; 1969 Nov; 130(5):1107-22. PubMed ID: 4899853 [TBL] [Abstract][Full Text] [Related]
15. Participation of immunoglobulin-bearing lymphocytes in the production of macrophage migration inhibitory factor. Pick E; Godny Y; Gold EF Eur J Immunol; 1975 Aug; 5(8):584-7. PubMed ID: 789092 [TBL] [Abstract][Full Text] [Related]
16. Alloantiserum-induced inhibition of immune response gene product function. I. Cellular distribution of target antigens. Shevach EM; Paul WE; Green I J Exp Med; 1974 Mar; 139(3):661-78. PubMed ID: 4591174 [TBL] [Abstract][Full Text] [Related]
17. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Bacher M; Metz CN; Calandra T; Mayer K; Chesney J; Lohoff M; Gemsa D; Donnelly T; Bucala R Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7849-54. PubMed ID: 8755565 [TBL] [Abstract][Full Text] [Related]
18. Lymphokines. I. Use of insoluble concanavalin A for the production of migration inhibitory factor in guinea pig lymphocyte cultures. Friedrich W; Lazary S; Geczy C; de Weck AL Int Arch Allergy Appl Immunol; 1975; 49(4):504-18. PubMed ID: 1099010 [TBL] [Abstract][Full Text] [Related]
19. The behavior of hapten-poly-L-lysine conjugates as complete antigens in genetic responder and as haptens in nonresponder guinea pigs. Green I; Paul WE; Benacerraf B J Exp Med; 1966 May; 123(5):859-79. PubMed ID: 5938816 [TBL] [Abstract][Full Text] [Related]
20. Differential expression of migration inhibitory and migration stimulatory factors in two lines of mice genetically selected for high or low responsiveness to phytohemagglutinin. 1. Migration stimulatory factor(s) from T and B cells of immune spleen. Gauthier-Rahman S; el-Gharbi N; Siddiqui MU; Couderc J; Decreusefond C; Stiffel C Exp Clin Immunogenet; 1991; 8(3):140-58. PubMed ID: 1799458 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]